medigraphic.com
ISSN 2221-2434 (Electronic)

2022, Number 1

<< Back

Finlay 2022; 12 (1)

Giant Hepatocellular Carcinoma in Cirrhotic Liver. Case Report and Literature Review

Montes de Oca MJL, Cisneros CA, Pérez BJ

Language: Spanish
References: 12
Page: 117-125
PDF size: 477.40 Kb.


ABSTRACT

Hepatocellular carcinoma is the most common primary liver neoplasm. It is the sixth most common tumor in the world, between 500,000 and one million cases diagnosed each year, and is the second most common cause of death from cancer. The disease develops almost exclusively in patients with underlying chronic liver disease, 85 to 95 % of who have developed cirrhosis. Surgical treatment, resection or liver transplant, continues to be the choice. The case of a 55-years-old male patient with a history of health with symptoms of gastric fullness, hematemesis or melena is presented. Physical examination revealed a tumor of more than 16 centimeters palpable in the epigastrium. By abdominal ultrasonography and simple and contrasted tomography, the initial diagnosis was made of a giant hepatocellular carcinoma of more than 16 centimeters in segments II and III. Surgical resection of the tumor was performed, confirming by the anatomopathological study a well-differentiated hepatocellular carcinoma with cirrhotic liver. After 6 months of surgery, favorable clinical and tomographic evolution was confirmed. Hepatocellular carcinoma continues to be a rare entity for which surgical resection is a therapeutic option. An atypical case diagnosed and operated on for giant hepatocellular carcinoma with a cirrhotic liver is presented.


REFERENCES

  1. Talens P. Actualización del tratamiento del carcinoma hepatocelular en el paciente con cirrosis hepática[Internet]. Barcelona:Universidad Autónoma de Barcelona;2017[citado 23 Sep 2020]. Disponible en: Disponible en: https://ddd.uab.cat/pub/tfg/2017/180638/Talens_Orts_Paula.pdf .

  2. Araneda G, Poniachik R, Freundlich A, Carreño L, Poniachik J. Tumores hepáticos primarios malignos no hepatocarcinoma ni colangiocarcinoma. Rev Med Chile[Internet]. 2019[citado 12 May 2021];147(6):[aprox. 5p.]. Disponible en: https://scielo.conicyt.cl/pdf/rmc/v147n6/0717-6163-rmc-147-06-0751.pdf.

  3. Piscoya A, Atamari N, Suker C, Corahua M, Parra A. Tendencia nacional de la mortalidad por hepatocarcinoma registrada en el Ministerio de Salud del Perú del 2005 al 2016. Acta Gastroenterol Latinoam[Internet]. 2020[citado 23 Oct 2021];50(3):[aprox. 7p]. Disponible en: https://www.actagastro.org/numeros-anteriores/2020/Vol-50-N3/Vol50N3-PDF16.pdf.

  4. Reig M, Forner A, Ávila MA, Ayuso C, Mínguez B, Varela M, et al. Diagnóstico y tratamiento del carcinoma hepatocelular. Actualización del documento de consenso de la AEEH, AEC, SEOM, SERAM, SERVEI y SETH. Med Clin[Internet]. 2016[citado 12 Feb 2020];146(11):[aprox. 10p.] Disponible en: https://www.elsevier.es/es-revista-medicina-clinica-2-avance-resumen-diagnostico-tratamiento-del-carcinoma-hepatocelular--S0025775320307697.

  5. Marrero JA, Kulik LM, Sirlin CB, Shu AX, Finn RS, Abecassis MM, et al. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018. Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723-50.

  6. López M, López J, Monteagudo B, Álvarez EJ. Hepatocarcinoma gigante unifocal en mujer con ingesta prolongada de anticonceptivos hormonales: ¿casualidad o causalidad? Galicia Clin[Internet]. 2016[citado 30 Nov 2020];77(4):[aprox. 6p.]. Disponible en: https://galiciaclinica.info/PDF/GC77-4.pdf.

  7. Martínez G, Esquivel S, Casanova IE, Escobar AY, Troche JM, Yoldi CA. Carcinoma hepatocelular en hígado no cirrótico: características clínicas y resultados en Veracruz, México. Rev Gastroenterol Méx[Internet]. 2021[citado 17 Ene 2022];86(1):[aprox. 10p.]. Disponible en: https://www.revistagastroenterologiamexico.org/es-carcinoma-hepatocelular-higado-no-cirrotico-articulo-S0375090620300379.

  8. Erazo AA, Bautista A, Calderillo G, Campos S, Cervantes G, Cortés S, et al. Recomendaciones interinstitucionales sobre el diagnóstico y tratamiento del hepatocarcinoma avanzado. Rev Esp Méd Quir[Internet]. 2018[citado 12 Sep 2020];23(1):[aprox. 9p.]. Disponible en: https://www.medigraphic.com/pdfs/quirurgicas/rmq-2018/rmq181f.pdf.

  9. Lünse S, Döringb P, Heideckea CD, Partecke LI. Giant hepatocellular carcinoma with bone metastasis in a young adult, emerged from pigmented adenoma with beta-Catenin activation: A case report. Int J Surg Case Rep. 2017;36(1):18-21.

  10. Molina KB, Vargas AL, Salgado SJ, Beltrán C, Nagore JF, Jiménez A. Revisión de carcinoma hepatocelular sarcomatoide y presentación de un caso. Cir Gen[Internet]. 2019[citado 19 Abr 2021];41(4):[aprox. 7p.]. Disponible en: https://www.medigraphic.com/cgi-bin/new/contenido.cgi?IDPUBLICACION=8629.

  11. González C, Mancilla S. Avances en imagenología hepática: carcinoma hepatocelular y colangiocarcinoma. Acta Méd Grup Ángeles[Internet]. 2016[citado 6 Feb 2020];14(Suppl. 1):[aprox. 6p.]. Disponible en: https://www.medigraphic.com/cgi-bin/new/contenido.cgi?IDPUBLICACION=6657.

  12. Díaz LA, Barrera F. Clasificación Barcelona Clinic Liver Cancer (BCLC) de carcinoma hepatocelular. Gastroenterol Latinoam[Internet]. 2015[citado 23 Ene 2020];26(1):[aprox. 6p.]. Disponible en: https://gastrolat.org/DOI/PDF/10.0716/gastrolat2015n100009.pdf.




2020     |     www.medigraphic.com